Wilkins Investment Counsel Inc. reduced its position in Colgate-Palmolive (NYSE:CL) by 1.5% in the 1st quarter, HoldingsChannel reports. The fund owned 65,150 shares of the company’s stock after selling 1,000 shares during the quarter. Colgate-Palmolive comprises approximately 1.5% of Wilkins Investment Counsel Inc.’s holdings, making the stock its 29th largest position. Wilkins Investment Counsel Inc.’s holdings in Colgate-Palmolive were worth $4,670,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. grew its position in shares of Colgate-Palmolive by 1.4% during the fourth quarter. BlackRock Inc. now owns 52,360,691 shares of the company’s stock worth $3,950,614,000 after buying an additional 711,972 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of Colgate-Palmolive by 11.3% during the first quarter. Wells Fargo & Company MN now owns 9,886,686 shares of the company’s stock worth $708,678,000 after buying an additional 1,003,612 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Colgate-Palmolive by 2.1% during the fourth quarter. Geode Capital Management LLC now owns 8,975,479 shares of the company’s stock worth $675,751,000 after buying an additional 188,455 shares in the last quarter. First Eagle Investment Management LLC grew its position in shares of Colgate-Palmolive by 45.7% during the first quarter. First Eagle Investment Management LLC now owns 7,830,595 shares of the company’s stock worth $561,297,000 after buying an additional 2,455,839 shares in the last quarter. Finally, OppenheimerFunds Inc. grew its position in shares of Colgate-Palmolive by 2.8% during the fourth quarter. OppenheimerFunds Inc. now owns 6,173,804 shares of the company’s stock worth $465,813,000 after buying an additional 166,537 shares in the last quarter. 74.26% of the stock is owned by institutional investors.
Get Colgate-Palmolive alerts:
Shares of Colgate-Palmolive opened at $62.22 on Friday, according to Marketbeat. The company has a debt-to-equity ratio of 64.85, a current ratio of 1.08 and a quick ratio of 0.75. Colgate-Palmolive has a 52-week low of $61.28 and a 52-week high of $77.91. The company has a market capitalization of $54.28 billion, a P/E ratio of 21.16, a price-to-earnings-growth ratio of 2.46 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, April 27th. The company reported $0.74 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 1,486.69% and a net margin of 13.30%. The company had revenue of $4 billion during the quarter, compared to analysts’ expectations of $4.01 billion. During the same quarter in the previous year, the business earned $0.67 earnings per share. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. sell-side analysts predict that Colgate-Palmolive will post 3.17 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 15th. Shareholders of record on Friday, April 20th were paid a $0.42 dividend. The ex-dividend date of this dividend was Thursday, April 19th. This represents a $1.68 dividend on an annualized basis and a yield of 2.70%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s payout ratio is currently 58.54%.
In other Colgate-Palmolive news, Vice Chairman Franck J. Moison sold 80,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 15th. The stock was sold at an average price of $61.75, for a total value of $4,940,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP John J. Huston sold 1,524 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $70.17, for a total value of $106,939.08. Following the completion of the sale, the senior vice president now owns 87,376 shares of the company’s stock, valued at approximately $6,131,173.92. The disclosure for this sale can be found here. In the last quarter, insiders sold 184,142 shares of company stock valued at $11,933,716. 1.02% of the stock is owned by company insiders.
CL has been the subject of a number of analyst reports. ValuEngine downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Citigroup upped their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Tuesday, January 30th. Zacks Investment Research raised Colgate-Palmolive from a “sell” rating to a “hold” rating in a report on Tuesday, April 17th. Finally, Morgan Stanley downgraded Colgate-Palmolive from an “overweight” rating to an “equal weight” rating in a report on Monday, April 30th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $76.75.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).